Krónikus obstruktív tüdőbetegség (COPD): ki dolgozik rajta

Intézményenként egy kártya. Szűrhetsz célpontra, országra, vagy csak az EU-13 (Horizon Europe felzárkózó) országok intézményeire.

Az EU-13 szűrő, nem rangsor: csak szűkíti a listát.

200+ intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

  NCT07874815· Merck Sharp & Dohme LLC· Forrás

• The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.

  NCT07923656· University Hospital, Bordeaux· Forrás

• Local Antibiotic Delivery for Community Acquired Pneumonia

  NCT06859450· Copenhagen Respiratory Research· Forrás

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

  NCT07725939· UCB Biopharma SRL· Forrás

• A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

  NCT06154837· GlaxoSmithKline· Forrás

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  NCT07780656· GlaxoSmithKline· Forrás

• A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  NCT07759245· Eli Lilly and Company· Forrás

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  NCT07780669· GlaxoSmithKline· Forrás

• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  NCT07051707· Nuvaira, Inc.· Forrás

• WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

  NCT07558265· Ohio State University· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 25
• Organoids 7
• Mendelian Randomization Analysis 68
• CRISPR-Cas Systems 1
• Gene Expression Profiling 68
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 4
• Proteomics 31
• Metabolomics 34
• Mass Spectrometry 5
• Flow Cytometry 5
• Immunohistochemistry 5
• Liquid Biopsy 2
• Circulating Tumor DNA 1
• Magnetic Resonance Imaging 32
• Machine Learning 103
• Deep Learning 33
• Cohort Studies 225
• Genome-Wide Association Study 71

• CXCL12: a key gene in IPF-COPD pathogenesis and its therapeutic potential.

  J Transl Med, 2026. okt.

• PANoptosis gene signatures identify candidate biomarkers and genetically associated genes in COPD.

  J Glob Health, 2026. okt.

• Integrative Single-Cell and Bulk RNA Sequencing Analysis Identifies Ion Channel-Related Biomarkers in Chronic Obstructive Pulmonary Disease.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Identification of Five Candidate Genes and Development of an Exploratory Diagnostic Nomogram for COPD Using Integrative Single-Cell and Bulk Transcriptomic Analyses.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Single-cell analysis of COPD: Microenvironmental interactions driven by immune-fibrotic imbalance.

  PLoS One, 2026. okt.

• Association of Lung Tissue MicroRNA Expression with Quantitative Emphysema in COPD: An Exploratory Transcriptomic Analysis.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Revealing Biomarkers and Candidate Drugs for Chronic Obstructive Pulmonary Disease Using Bioinformatics and Deep Learning.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Single-Cell Transcriptomics Reveals Macrophage Dysfunction and cDC2 Activation in COPD: Candidate Biomarkers for Individualized Nursing Care.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Identification and Validation of a Two-Gene NK Cell-Related Risk Model for COPD: Integration of Single-Cell and Bulk RNA-Seq Analysis.

  Int J Chron Obstruct Pulmon Dis, 2026. szept.

• UPP1 as a Diagnostic Biomarker: Insights from Integrative Bioinformatics and Immune Infiltration Analyses in COPD.

  J Vis Exp, 2026. szept.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.